Enzyme-Linked Immunosorbent assays (ELISA) have been used for decades in research and development, disease diagnosis and other critical fields in sciences. Due to limitations in sample volumes and the need to reduce assay time and costs, new technologies have been developed. These methodologies, in contrast to the conventional ELISA assays, allow the researcher to test many analytes at one time. While some other multiplex technologies test only one or a few samples at a time, Quansys has developed a platform that maintains the throughput of an ELISA while delivering the advantages of multiplexing. As well, when comparing the Q-Plex Technology to other multiplex technologies, the savings of time, sample and money are easily seen.